UVDI Joins APIC to Counter Misinformation and Uplift Science During International Infection Prevention Week

To raise awareness about the importance of infection prevention and the essential role infection preventionists (IPs) play in public health, UVDI, the leading manufacturer of advanced Ultraviolet technology for Hospital Room Disinfection and Indoor Air Quality, is joining the Association for Professionals in Infection Control and Epidemiology (APIC) as a Corporate Sponsor for International Infection Prevention Week (IIPW), October 17–23.

UVDI has introduced several new educational resources for safe, effective UV room disinfection to emphasize the science behind infection prevention, the misinformation that continues to circulate, and how to inspire the next generation of IPs to join the fight. Educational Resources include a series of new Continuing Education webinars including Fact Versus Fiction: Clarifying Myths Regarding UV Room Disinfection, and three whitepapers sharing UV Basics and Beyond. All are accessible on UVDI’s online Learning Hub at www.uvdi.com.

As IPs continue to protect communities from surges in COVID-19 cases and healthcare-associated infections (HAIs), it has never been clearer just how crucial infection prevention and control is to everyone’s health and safety. In recognition of the role that everyone should play in infection prevention, the 2021 IIPW theme is “Make Your Intention Infection Prevention.” APIC has developed downloadable infographics, fact sheets, and social media materials to help educate all audiences on infection prevention and control—the science behind it and its legitimacy as a trusted profession in the healthcare space.

“We honor the dedication and selflessness of Infection Prevention professionals – this week and every week,” said Peter Veloz, CEO, UVDI. “Working with APIC to provide fact-based evidence and resources for safe, effective UV disinfection is a core part of our ongoing commitment to better patient outcomes.”

“We are happy to have UVDI join our other Corporate Sponsors for this year’s International Infection Prevention Week,” said APIC President Ann Marie Pettis, RN, BSN, CIC, FAPIC. “With their help, we are able to reach consumers and other healthcare personnel about how they can make their intention infection prevention.”

UVDI plans to join APIC and other healthcare organizations on Tuesday, October 19 at 12 PM ET for a Twitter chat using #IIPWChat to discuss the impacts of COVID-19, how to counter misinformation with facts, and what it looks like to be an IP. Learn more at www.InfectionPreventionandYou.org/iipw.

SourceUVDI

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.